News & Updates
Bivalent COVID-19 Booster Vaccine Recommended for 12 Years and Older
Background: On August 31, 2022, the U.S. Food and Drug Administration (FDA) issued amended Emergency Use Authorizations (EUAs) to both Moderna and Pfizer-BioNTech to authorize their bivalent formulations of the...
Updated Guidance: Isolation and Precautions for People with COVID-19
Background The Centers for Disease Control and Prevention (CDC) updated their isolation guidance on August 11, 2022, for persons with COVID-19.1 Individuals with COVID-19 can spread the virus to others...
Monkeypox Virus Vaccine Guidance and Recommendations
Background According to the Centers for Disease Control and Prevention (CDC), since monkeypox virus is closely related to the virus that causes smallpox, the smallpox vaccine can protect people from...
Moderna COVID-19 Vaccine Approved for Children and Adolescents 6-17 years
Background: On June 14, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to recommend the authorization and use of the Moderna mRNA COVID-19 vaccine, for children and...
Pediatric COVID-19 Vaccines Recommended for Children Aged 6 mo – 5 years
Background: On June 15, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend the authorization of both the Moderna COVID-19 vaccine two-dose primary series for...
Pfizer-BioNTech COVID-19 Vaccine Booster Dose for Children 5-11 Years
Background: On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This amendment authorizes administration of a single...
CDC and Health Partners Responding to Monkeypox Case in the U.S
Summary On May 20, 2022, the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory to notify clinicians, hospitals, laboratories and public health authorities...
Updates to COVID-19 Laboratory Reporting Requirements
Background: Entities in Nevada that have performed or analyzed a test intended to detect SARS-CoV-2 or to diagnose a possible case of COVID-19 have been mandated to report all results...
Developing and maintaining written plans that balance access to care, staffing shortages and infection control.
Background: COVID-19 has highlighted some risks involved in resident care, particularly in skilled nursing facilities and other congregate living settings. There are several competing priorities, and it is difficult to...
Update: COVID-19 Point of Care Antigen Testing in Community Settings
Background: Point of care (POC) COVID-19 antigen tests are one testing option available to respond to the COVID-19 pandemic. Antigen tests are immunoassays that detect the presence of a specific...
Clinical Laboratory Submission to State and Local Public Health Laboratories
Background Nevada Administrative Code (NAC) 441A.235 requires clinical/medical laboratories to submit microbiological cultures, subcultures, or other specimens or clinical material to the State Public Health Laboratory or other laboratory designated...
Updated Tuberculosis (TB) Testing Recommendations Around COVID-19 Vaccinations
Situation: On August 31, 2021, the Centers for Disease Control and Prevention (CDC) updated its interim guidance on clinical considerations for use of the COVID-19 vaccines and included guidance on...